Hiram Maldonado Rivera
Endocrinology, Diabetes & Metabolism · Bayamon, PRNPI 1871049536
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 272 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,861 and has fallen 91.3% since, to $249 in 2025.
Across 272 payments — averaging $24.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$753
- Lilly USA, LLC$690
- Amgen$683
- Boehringer Ingelheim$479
- Kyowa Kirin, Inc.$368
- Sanofi-aventis U.S. LLC$342
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,688100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $753 |
| Lilly USA, LLC | 37 | $690 |
| Amgen | 17 | $683 |
| Boehringer Ingelheim | 21 | $479 |
| Kyowa Kirin, Inc. | 9 | $368 |
| Sanofi-aventis U.S. LLC | 10 | $342 |
| Xeris Pharmaceuticals, Inc. | 18 | $300 |
| Corcept Therapeutics | 17 | $298 |
| AstraZeneca(2 entities) | 9 | $267 |
| Mannkind Corporation | 9 | $260 |
| Radius Health, Inc. | 14 | $222 |
| Insulet Corporation | 4 | $209 |
| Medtronic | 9 | $208 |
| Tandem Diabetes Care, Inc. | 6 | $208 |
| GSK | 2 | $191 |
| Dexcom, Inc. | 10 | $181 |
| Amneal Pharmaceuticals LLC | 10 | $169 |
| Novartis | 7 | $126 |
| Mylan Specialty L.p. | 1 | $101 |
| E.r. Squibb & Sons, L.L.C. | 1 | $97 |
| Recordati_rare_diseases_inc. | 5 | $93 |
| PBG Puerto Rico LLC | 3 | $63 |
| Halozyme Inc | 3 | $61 |
| AbbVie | 4 | $58 |
| IBSA Pharma Inc. | 3 | $54 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Embecta Corp. | 2 | $33 |
| Ascensia Diabetes Care US Inc. | 2 | $31 |
| Bayer | 1 | $26 |
| Boston Scientific | 2 | $25 |
| Johnson & Johnson | 1 | $22 |
| Amphastar Pharmaceuticals, Inc. | 1 | $22 |
| Cardinal Health 414 LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,700 in reported general payments places this provider in the 60th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Other endocrinology, diabetes & metabolism in Bayamon
- Altagracia Alcantara GonzalezBayamon$58K
- Jean Pujals KuryBayamon$50K
- Paola Mansilla-LetelierBayamon$33K
- Angel Comulada RiveraBayamon$31K
- Gloria Vega CarattiniBayamon$26K
- Jose Garcia MateoPonce$945K
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.